Funding for this research was provided by:
National Natural Science Foundation of China (81272710)
Wu Jieping’s Foundation Special for Clinical Research (320.6750.2021-04-02)
Article History
Received: 29 April 2022
Accepted: 15 August 2022
First Online: 4 October 2022
Declarations
:
: Dr Jianqiang Tang, Junguang Liu, Binbin Du, Junling Zhang, Lijun Zheng, Xin Wang, and Yuanlian Wan have no conflict of interest or financial ties to disclose.
: All work was carried out in compliance with the Ethical Principles for Medical Research Involving Human Subjects outlined in the Helsinki Declaration in 1975 (revised in 2000).
: All patients enrolled provided written informed consent, and this study was approved by Peking University First Hospital ethics committee of biomedical research (2021–351).